TRAF6 and neurodegenerative disease: Numerous studies have reported TRAF6 upregulation associated with CNS damage due to TBI, stroke, neurodegenerative diseases, and neuropathies (Chen et al., 2011, 2019; Aarts et al., 2017; Dou et al., 2018; Wu et al., 2018).